Skip Navigation

News & Resources

 

Subscribe to NHLBI Press Releases
May 22, 2017

COPD National Action Plan aims to reduce the burden of the third leading cause of death

The National Heart, Lung, and Blood Institute (NHLBI), along with federal and non-federal partners, today released the first-ever COPD National Action Plan, a detailed, patient-centered roadmap for addressing one of the most urgent health concerns facing Americans. The plan was released at the American Thoracic Society International Conference meeting this week in Washington, D.C. NHLBI is part of the National Institutes of Health.

May 15, 2017

High blood pressure linked to racial segregation in neighborhoods

Living in racially segregated neighborhoods is associated with a rise in the blood pressure of black adults, while moving away from segregated areas is associated with a decrease —and significant enough to lead to reductions in heart attacks and strokes, a National Institutes of Health-funded study has found.      

Subscribe to NHLBI In The News
May 23, 2017 : MedPage Today

The COPD National Action Plan, released at the American Thoracic Society International Conference meeting this week in Washington, D.C., is a detailed, patient-centered roadmap that aims to reduce the burden of the third leading cause of death.

MedicalXpress: New COPD action plan outlines strategies for improved care

EurekAlert!: ATS 2017: New COPD action plan outlines strategies for improved care

Medpage: NHLBI Unveils COPD National Action Plan

May 18, 2017 : The New England Journal of Medicine

Mast cells, a type of white blood cell, are present in the airways of severe asthmatics even in the face of aggressive treatment. In a new, proof-of-principle study published in the New England Journal of Medicine, NHLBI-funded researchers found that targeting the mast cells with imatinib, a drug used in cancer treatments, improved airway hyperresponsiveness, a measure of the sensitivity of the airway, and decreased the number of mast cells present in the airway.

STAT: Blockbuster cancer drug shows surprising promise in treating severe asthma

Pharmacy Times: Could This Cancer Drug Benefit Patients with Severe Asthma?

Drug Discovery and Development: Study Finds Imatinib Improves Symptoms for Patients with Severe Asthma

Medical Xpress: Proof-of principle study finds imatinib improves symptoms for patients with severe asthma

Washington University School of Medicine: Cancer drug may help patients with severe asthma

May 19, 2017 to May 24, 2017
Walter E. Washington Convention Center. 801 Mt Vernon Pl NW, Washington, DC 20001
The National Heart, Lung, and Blood Institute (NHLBI) will be participating in the American Thoracic Society International Conference in Washington, DC from May 19-24, 2017. NHLBI research and NHLBI-funded research will be presented at more than 20 sessions. See the schedule below for a snapshot of NHLBI’s sessions at ATS 2017.
October 26, 2017 to October 27, 2017
Jamaica Pegasus Hotel, Jamaica West Indies
The 11th annual SCiF conference will be co-hosted by the National Heart, Lung, and Blood Institute and The University of West Indies.